225 related articles for article (PubMed ID: 20559649)
1. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
El-Shennawy GA; Elbialy AA; Isamil AE; El Behery MM
Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
[TBL] [Abstract][Full Text] [Related]
2. CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women.
Ye Y; Cheng X; Luo HB; Liu L; Li YB; Hou YP
J Assist Reprod Genet; 2008 Aug; 25(8):389-94. PubMed ID: 18763031
[TBL] [Abstract][Full Text] [Related]
3. Combination effect of cytochrome P450 1A1 gene polymorphisms on uterine leiomyoma: A case-control study.
Salimi S; Sajadian M; Khodamian M; Yazdi A; Rezaee S; Mohammadpour-Gharehbagh A; Mokhtari M; Yaghmaie M
Bosn J Basic Med Sci; 2016 Aug; 16(3):209-14. PubMed ID: 27333216
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.
Villanova FE; Andrade PM; Otsuka AY; Gomes MT; Leal ES; Castro RA; Girão MJ; Nishimura E; Baracat EC; Silva ID
Steroids; 2006 Nov; 71(11-12):960-5. PubMed ID: 16935316
[TBL] [Abstract][Full Text] [Related]
5. The role of MSP I CYP1A1 gene polymorphism in the development of uterine fibroids.
Barão MA; Oliveira E; Gomes MT; da Silva ID; Sartori MG; Girão MJ; Castro Rde A
Fertil Steril; 2010 Dec; 94(7):2783-5. PubMed ID: 20579990
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
[TBL] [Abstract][Full Text] [Related]
7. CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population.
Sillanpää P; Heikinheimo L; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Metsola K; Hirvonen A
Breast Cancer Res Treat; 2007 Sep; 104(3):287-97. PubMed ID: 17063266
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor alpha-351 XbaI*G and -397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma.
Hsieh YY; Wang YK; Chang CC; Lin CS
Mol Hum Reprod; 2007 Feb; 13(2):117-22. PubMed ID: 17121748
[TBL] [Abstract][Full Text] [Related]
9. Role of single nucleotide polymorphisms in estrogen-metabolizing enzymes and susceptibility to uterine leiomyoma in Han Chinese: a case-control study.
Shen Y; Xu Q; Ren M; Cai Y; Xu J
J Obstet Gynaecol Res; 2014 Apr; 40(4):1077-84. PubMed ID: 24320736
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P2A13 and P1A1 gene polymorphisms are associated with the occurrence of uterine leiomyoma.
Herr D; Bettendorf H; Denschlag D; Keck C; Pietrowski D
Arch Gynecol Obstet; 2006 Oct; 274(6):367-71. PubMed ID: 16835796
[TBL] [Abstract][Full Text] [Related]
11. Association of the CYP17 gene polymorphism with risk for uterine leiomyoma in Brazilian women.
Vieira LC; Gomes MT; Castro Rde A; de Souza NC; da Silva ID; Baracat EC; Girão MJ
Gynecol Endocrinol; 2008 Jul; 24(7):373-7. PubMed ID: 18645709
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
13. CYP1A1 gene polymorphisms and smoking status as modifier factors for lung cancer risk.
Hussein AG; Pasha HF; El-Shahat HM; Gad DM; Toam MM
Gene; 2014 May; 541(1):26-30. PubMed ID: 24613751
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic variation of CYP1A1 and CYP1B1 genes in a Haryana population.
Giri SK; Yadav A; Kumar A; Dev K; Gulati S; Gupta R; Aggarwal N; Gautam SK
Biochem Genet; 2013 Dec; 51(11-12):853-64. PubMed ID: 23839087
[TBL] [Abstract][Full Text] [Related]
15. [Association of the CYP1B1 gene polymorphism with susceptibility to endometriosis].
Li YG; Wang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):66-9. PubMed ID: 19199255
[TBL] [Abstract][Full Text] [Related]
16. No association between estrogen receptor beta polymorphisms and uterine leiomyoma.
Zhai XD; Ye Y; Yang Y; Wang Z; Mo YN
DNA Cell Biol; 2009 Dec; 28(12):633-6. PubMed ID: 19715484
[TBL] [Abstract][Full Text] [Related]
17. The -2549 insertion/deletion polymorphism of VEGF gene associated with uterine leiomyoma susceptibility in women from Southeastern Iran.
Keshavarzi F; Salimi S; Mohammadpour-Gharehbagh A; Teimoori B; Yazdi A; Farajian-Mashhadi F; Yaghmaei M; Mokhtari M
Ginekol Pol; 2017; 88(3):115-119. PubMed ID: 28397198
[TBL] [Abstract][Full Text] [Related]
18. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
Shen Y; Li DK; Wu J; Zhang Z; Gao E
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
[TBL] [Abstract][Full Text] [Related]
19. A multicenter case-control study on screening of single nucleotide polymorphisms in estrogen-metabolizing enzymes and susceptibility to uterine leiomyoma in han chinese.
Shen Y; Ren ML; Xu J; Xu Q; Ding YQ; Wu ZC; Zhang HB; Huang XX; Cai YL
Gynecol Obstet Invest; 2014; 77(4):224-30. PubMed ID: 24777039
[TBL] [Abstract][Full Text] [Related]
20. Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss.
Saijo Y; Sata F; Yamada H; Suzuki K; Sasaki S; Kondo T; Gong YY; Kato EH; Shimada S; Morikawa M; Minakami H; Kishi R
Mol Hum Reprod; 2004 Oct; 10(10):729-33. PubMed ID: 15299091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]